Processa Pharmaceuticals Inc Fireside Chat Transcript
Ladies and gentlemen, thank you for standing by. Good afternoon and welcome to Processa Pharmaceuticals clinical update fireside chat. (Operator Instructions)
Participants on this call are advised that the audio of this conference call is being broadcast live over the Internet. A webcast replay of the call will be available approximately one hour after the call ends through June 20, 2024.
I would now like to turn the call over to Dr. Michael Beaubaire of Core IR, the company's Investor Relations firm. Please go ahead, sir.
Good afternoon. I am Dr. Michael Beaubaire, Chief Strategist Officer of Core IR, and thank you for participating in today's conference call. Joining me from Processa Pharmaceuticals' leadership team are George Ng, Chief Executive Officer, and Dr. David Young, Pharm.D., Ph.D., President of R&D.
During this call, management will be making forward-looking statements, including statements that address Processa's expectations for future performance or
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |